We’ve just launched a new portal to help you explore stocks, crypto, ETFs, and more data

RGLS

7.92000 USD
0.03
0.38%
Last update May 21, 3:59 PM EDT
Market closed
Day range
7.88000
7.97500
Previous close
7.95000
Open
7.91000
Access this stock data via API
Subscribe
Regulus Therapeutics Inc.
7.92
0.03
0.38%

Financials

Income statement

Fiscal date Mar 2025 Dec 2024 Sep 2024 Jun 2024
Total reported revenue 0 0 0 0
Cost of revenue
Gross profit
Operating expense
Research & development 6.8M 9.7M 11.3M 8.3M
Selling general and admin 3.7M 4.1M 3.9M 4.0M
Other operating expenses
Operating income -10.5M -13.7M -15.2M -12.3M
Non operating interest income
Income 921K 968K 1.2M 1.3M
Expense 17K 13K 5K 58K
Other income expense
Pretax income -9.6M -12.8M -14.1M -11.0M
Tax provision 0 0 1K
Net income -9.6M -12.8M -14.1M -11.0M
Basic EPS -0.2 -0.2 -0.2 -0.2
Diluted EPS -0.2 -0.2 -0.2 -0.2
Basic average shares 66.2M 65.5M 65.5M 64.5M
Diluted average shares 66.2M 65.5M 65.5M 64.5M
EBITDA -9.5M -12.7M -14.0M -10.9M
Net income from continuing op. -9.6M -12.8M -14.1M -11.0M
Minority interests
Preferred stock dividends
Market closed

Exchange is currently closed
Pre-market opens in 7 hours 38 minutes

20:21
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EDT, UTC-04:00).